Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0
|
作者：
Muddu, V. [1 ]
Shah, A. [2 ]
Raj, A. [3 ]
Bahl, A. [4 ]
Thirumalairaj, R. [5 ]
Ghosh, J. [6 ]
Ostwal, V. [2 ]
Rajappa, S. [7 ]
Vora, A. [8 ]
Lavingia, V. [9 ]
Sharma, A. [10 ]
Khan, A. [1 ]
Rohatgi, N. [4 ]
Mahajan, M. [11 ]
Chandrakanth, M. [6 ]
Ramaswamy, A. [12 ]
机构：
[1] AIG Hosp, Hyderabad, India
[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India
[3] Sarvodaya Hosp, Faridabad, India
[4] Fortis Canc Inst, Gurgaon, India
[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India
[6] Tata Med Ctr, Kolkata, India
[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India
[8] HOPE Oncol Care Clin, New Delhi, India
[9] HCG Canc Ctr, Ahmadabad, Gujarat, India
[10] All India Inst Med Sci, New Delhi, India
[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India
[12] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-209
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [41] Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
    Wang, Yaoqun
    Wen, Ningyuan
    Wang, Shaofeng
    Nie, Guilin
    Tian, Yuan
    Lu, Jiong
    Li, Bei
    BMC CANCER, 2023, 23 (01)
  • [42] Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents
    Casolino, Raffaella
    Braconi, Chiara
    HEPATOMA RESEARCH, 2021, 7
  • [43] Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
    Yaoqun Wang
    Ningyuan Wen
    Shaofeng Wang
    Guilin Nie
    Yuan Tian
    Jiong Lu
    Bei Li
    BMC Cancer, 23
  • [44] A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Wang, Lijie
    Zhang, Sujie
    Chen, Guangying
    Li, Xiaoyan
    Cui, Pengfei
    Zheng, Xuan
    Hu, Yi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1421 - +
  • [45] Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
    Reibel, J. B.
    Hubbard, R.
    Sun, L.
    Parikh, R. B.
    Martin, L. P.
    Mamtani, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S942 - S943
  • [46] Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
    Mathers, Brittney
    Abadi, Shirin
    Davies, Janine M.
    McIntyre, Connor
    Ho, Cheryl
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 1381 - 1386
  • [47] Impact of adjuvant chemotherapy for patients with locally advanced upper tract urothelial carcinoma in real-world clinical practice
    Teishima, Jun
    Hirata, Junichiro
    Toge, Takuya
    Uematsu, Riku
    Mita, Yoshie
    Yoshii, Takahiko
    Nakamura, Ichiro
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (01): : E32 - E36
  • [48] Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark
    Omland, Lise Hoj
    Stormoen, Dag Rune
    Dohn, Line Hammer
    Carus, Andreas
    Als, Anne Birgitte
    Jensen, Niels Viggo
    Taarnhoj, Gry Assam
    Tolver, Anders
    Pappot, Helle
    BLADDER CANCER, 2021, 7 (04) : 413 - 425
  • [49] Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
    Simon Fung
    Yahiya Y. Syed
    Targeted Oncology, 2024, 19 (1) : 129 - 129
  • [50] Phase I/II clinical trial of regorafenib plus durvalumab (MEDI4736) in patients with chemotherapy-refractory advanced biliary tract cancers.
    Al-Rajabi, Raed Moh'd Taiseer
    Kasi, Anup
    Baranda, Joaquina Celebre
    Saeed, Anwaar
    Li, Haoran
    Bruey, Collin
    Best, Shaun
    Phadnis, Milind A.
    Sun, Weijing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS581 - TPS581
12345